Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents

Abstract

In treatment-experienced children and adolescents, DRV/r showed comparable exposure to adults with appropriate dose selection, favorable safety and tolerability, improved body weight and significant virologic response. DRV/r is a valuable therapeutic option for this population.